nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymetazoline—ADRA2A—type 2 diabetes mellitus	0.207	0.521	CbGaD
Oxymetazoline—HTR2C—type 2 diabetes mellitus	0.191	0.479	CbGaD
Oxymetazoline—HTR1D—Bromocriptine—type 2 diabetes mellitus	0.0539	0.116	CbGbCtD
Oxymetazoline—HTR2B—Bromocriptine—type 2 diabetes mellitus	0.0528	0.113	CbGbCtD
Oxymetazoline—ADRA1D—Bromocriptine—type 2 diabetes mellitus	0.0517	0.111	CbGbCtD
Oxymetazoline—HTR1B—Bromocriptine—type 2 diabetes mellitus	0.0517	0.111	CbGbCtD
Oxymetazoline—ADRA2C—Bromocriptine—type 2 diabetes mellitus	0.047	0.101	CbGbCtD
Oxymetazoline—ADRA2B—Bromocriptine—type 2 diabetes mellitus	0.0445	0.0957	CbGbCtD
Oxymetazoline—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.0376	0.0809	CbGbCtD
Oxymetazoline—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.0344	0.0738	CbGbCtD
Oxymetazoline—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.031	0.0666	CbGbCtD
Oxymetazoline—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.031	0.0666	CbGbCtD
Oxymetazoline—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.0297	0.0638	CbGbCtD
Oxymetazoline—HTR2A—arteriole—type 2 diabetes mellitus	0.00325	0.107	CbGeAlD
Oxymetazoline—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.00207	0.068	CbGeAlD
Oxymetazoline—Xylometazoline—ADRA2A—type 2 diabetes mellitus	0.002	1	CrCbGaD
Oxymetazoline—HTR1B—artery—type 2 diabetes mellitus	0.00164	0.0539	CbGeAlD
Oxymetazoline—HTR1D—artery—type 2 diabetes mellitus	0.00159	0.0522	CbGeAlD
Oxymetazoline—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.00139	0.0457	CbGeAlD
Oxymetazoline—HTR2A—hindlimb—type 2 diabetes mellitus	0.00129	0.0423	CbGeAlD
Oxymetazoline—NISCH—islet of Langerhans—type 2 diabetes mellitus	0.00123	0.0402	CbGeAlD
Oxymetazoline—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.00118	0.0388	CbGeAlD
Oxymetazoline—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.00101	0.033	CbGeAlD
Oxymetazoline—NISCH—nephron tubule—type 2 diabetes mellitus	0.000987	0.0324	CbGeAlD
Oxymetazoline—NISCH—pancreas—type 2 diabetes mellitus	0.000861	0.0283	CbGeAlD
Oxymetazoline—NISCH—cortex of kidney—type 2 diabetes mellitus	0.000844	0.0277	CbGeAlD
Oxymetazoline—HTR2A—artery—type 2 diabetes mellitus	0.00079	0.0259	CbGeAlD
Oxymetazoline—HTR2A—nerve—type 2 diabetes mellitus	0.000784	0.0257	CbGeAlD
Oxymetazoline—NISCH—adipose tissue—type 2 diabetes mellitus	0.000781	0.0256	CbGeAlD
Oxymetazoline—ADRA1B—kidney—type 2 diabetes mellitus	0.00074	0.0243	CbGeAlD
Oxymetazoline—HTR2A—endothelium—type 2 diabetes mellitus	0.000668	0.0219	CbGeAlD
Oxymetazoline—HTR1B—cardiovascular system—type 2 diabetes mellitus	0.000571	0.0187	CbGeAlD
Oxymetazoline—HTR1D—cardiovascular system—type 2 diabetes mellitus	0.000553	0.0181	CbGeAlD
Oxymetazoline—NISCH—liver—type 2 diabetes mellitus	0.000548	0.018	CbGeAlD
Oxymetazoline—HTR1D—kidney—type 2 diabetes mellitus	0.000541	0.0178	CbGeAlD
Oxymetazoline—HTR2B—cardiovascular system—type 2 diabetes mellitus	0.000514	0.0169	CbGeAlD
Oxymetazoline—HTR2B—cortex of kidney—type 2 diabetes mellitus	0.00049	0.0161	CbGeAlD
Oxymetazoline—HTR2B—adipose tissue—type 2 diabetes mellitus	0.000454	0.0149	CbGeAlD
Oxymetazoline—ADRA2C—nephron tubule—type 2 diabetes mellitus	0.000451	0.0148	CbGeAlD
Oxymetazoline—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000447	0.0147	CbGeAlD
Oxymetazoline—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.000425	0.0139	CbGeAlD
Oxymetazoline—ADRA2C—kidney—type 2 diabetes mellitus	0.000396	0.013	CbGeAlD
Oxymetazoline—ADRA2C—pancreas—type 2 diabetes mellitus	0.000393	0.0129	CbGeAlD
Oxymetazoline—ADRA2C—cortex of kidney—type 2 diabetes mellitus	0.000386	0.0127	CbGeAlD
Oxymetazoline—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.000375	0.0123	CbGeAlD
Oxymetazoline—ADRA2C—adipose tissue—type 2 diabetes mellitus	0.000357	0.0117	CbGeAlD
Oxymetazoline—HTR2A—retina—type 2 diabetes mellitus	0.000325	0.0107	CbGeAlD
Oxymetazoline—ADRA2A—pancreas—type 2 diabetes mellitus	0.000314	0.0103	CbGeAlD
Oxymetazoline—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.000308	0.0101	CbGeAlD
Oxymetazoline—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.000285	0.00935	CbGeAlD
Oxymetazoline—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000275	0.00901	CbGeAlD
Oxymetazoline—HTR2A—kidney—type 2 diabetes mellitus	0.000269	0.00882	CbGeAlD
Oxymetazoline—ADRA1A—liver—type 2 diabetes mellitus	0.000263	0.00862	CbGeAlD
Oxymetazoline—ADRA2C—liver—type 2 diabetes mellitus	0.00025	0.00822	CbGeAlD
Oxymetazoline—HTR2A—liver—type 2 diabetes mellitus	0.00017	0.00557	CbGeAlD
Oxymetazoline—ADRA1A—Signaling Pathways—C3—type 2 diabetes mellitus	3.72e-06	3.58e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—ALB—type 2 diabetes mellitus	3.71e-06	3.57e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.68e-06	3.55e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.67e-06	3.54e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.63e-06	3.49e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.62e-06	3.48e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—INS—type 2 diabetes mellitus	3.62e-06	3.48e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.61e-06	3.48e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—AGT—type 2 diabetes mellitus	3.61e-06	3.47e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.6e-06	3.46e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.56e-06	3.43e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—RELA—type 2 diabetes mellitus	3.56e-06	3.42e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—PIK3R1—type 2 diabetes mellitus	3.55e-06	3.41e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—NOS3—type 2 diabetes mellitus	3.55e-06	3.41e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.55e-06	3.41e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.54e-06	3.41e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.54e-06	3.4e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.53e-06	3.4e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—LEP—type 2 diabetes mellitus	3.53e-06	3.4e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—APOE—type 2 diabetes mellitus	3.53e-06	3.4e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—AGT—type 2 diabetes mellitus	3.53e-06	3.4e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.53e-06	3.4e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.52e-06	3.39e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.52e-06	3.39e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.52e-06	3.39e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.5e-06	3.37e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.5e-06	3.37e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.49e-06	3.36e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.49e-06	3.36e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.48e-06	3.35e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—INS—type 2 diabetes mellitus	3.48e-06	3.35e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.47e-06	3.35e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.47e-06	3.34e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.46e-06	3.34e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—APOE—type 2 diabetes mellitus	3.46e-06	3.33e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—LEP—type 2 diabetes mellitus	3.46e-06	3.33e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—C3—type 2 diabetes mellitus	3.45e-06	3.32e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.45e-06	3.32e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.42e-06	3.29e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.42e-06	3.29e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.41e-06	3.29e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.39e-06	3.27e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—INS—type 2 diabetes mellitus	3.38e-06	3.26e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.36e-06	3.24e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.36e-06	3.23e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—PPARG—type 2 diabetes mellitus	3.35e-06	3.22e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.35e-06	3.22e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.33e-06	3.21e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—INS—type 2 diabetes mellitus	3.33e-06	3.2e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.33e-06	3.2e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.32e-06	3.2e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—RELA—type 2 diabetes mellitus	3.31e-06	3.19e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.3e-06	3.17e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.29e-06	3.17e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.28e-06	3.16e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—INS—type 2 diabetes mellitus	3.28e-06	3.16e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—AGT—type 2 diabetes mellitus	3.28e-06	3.16e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.27e-06	3.15e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.27e-06	3.15e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.27e-06	3.15e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Hemostasis—AKT1—type 2 diabetes mellitus	3.27e-06	3.14e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.26e-06	3.14e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.26e-06	3.14e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.25e-06	3.13e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—PTGS2—type 2 diabetes mellitus	3.24e-06	3.12e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.24e-06	3.12e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.23e-06	3.11e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.23e-06	3.11e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.22e-06	3.1e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.22e-06	3.1e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—APOE—type 2 diabetes mellitus	3.21e-06	3.1e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—LEP—type 2 diabetes mellitus	3.21e-06	3.1e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.21e-06	3.09e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.2e-06	3.08e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.2e-06	3.08e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.19e-06	3.07e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.19e-06	3.07e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.19e-06	3.07e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.18e-06	3.06e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.17e-06	3.06e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.17e-06	3.06e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.15e-06	3.03e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.13e-06	3.01e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.11e-06	2.99e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.09e-06	2.97e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.06e-06	2.94e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.05e-06	2.93e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.05e-06	2.93e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—SRC—type 2 diabetes mellitus	3.04e-06	2.93e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.03e-06	2.92e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.03e-06	2.92e-05	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—IL6—type 2 diabetes mellitus	3.02e-06	2.91e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—INS—type 2 diabetes mellitus	3.02e-06	2.91e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.01e-06	2.9e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—ALB—type 2 diabetes mellitus	3.01e-06	2.9e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3e-06	2.89e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—RELA—type 2 diabetes mellitus	2.99e-06	2.88e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.98e-06	2.87e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—SRC—type 2 diabetes mellitus	2.97e-06	2.86e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.97e-06	2.86e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.97e-06	2.86e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.96e-06	2.85e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.96e-06	2.85e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.96e-06	2.85e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—INS—type 2 diabetes mellitus	2.96e-06	2.85e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.94e-06	2.83e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.92e-06	2.81e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.92e-06	2.81e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.92e-06	2.81e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.92e-06	2.81e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.91e-06	2.8e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.9e-06	2.8e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.9e-06	2.79e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—PIK3R1—type 2 diabetes mellitus	2.88e-06	2.77e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—NOS3—type 2 diabetes mellitus	2.88e-06	2.77e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—RELA—type 2 diabetes mellitus	2.87e-06	2.76e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.87e-06	2.76e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.86e-06	2.75e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.86e-06	2.75e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.84e-06	2.74e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.82e-06	2.72e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—SRC—type 2 diabetes mellitus	2.79e-06	2.69e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.79e-06	2.69e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—RELA—type 2 diabetes mellitus	2.79e-06	2.69e-05	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.79e-06	2.68e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.77e-06	2.67e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—RELA—type 2 diabetes mellitus	2.75e-06	2.64e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—INS—type 2 diabetes mellitus	2.75e-06	2.64e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.74e-06	2.63e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.72e-06	2.62e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.72e-06	2.62e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.72e-06	2.62e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.71e-06	2.61e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.7e-06	2.6e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.69e-06	2.59e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.68e-06	2.58e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.66e-06	2.56e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.66e-06	2.56e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.66e-06	2.56e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.65e-06	2.56e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.65e-06	2.55e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.65e-06	2.55e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.64e-06	2.54e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	2.63e-06	2.54e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.61e-06	2.51e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.61e-06	2.51e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—SRC—type 2 diabetes mellitus	2.6e-06	2.5e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.59e-06	2.5e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.59e-06	2.5e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.59e-06	2.49e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.57e-06	2.48e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.55e-06	2.45e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.54e-06	2.45e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.53e-06	2.44e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.52e-06	2.43e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.52e-06	2.43e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.52e-06	2.42e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.5e-06	2.41e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.5e-06	2.41e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.5e-06	2.41e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	2.49e-06	2.4e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.48e-06	2.39e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.47e-06	2.38e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.46e-06	2.37e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.45e-06	2.36e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.45e-06	2.35e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	2.44e-06	2.35e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.42e-06	2.33e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.41e-06	2.32e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.41e-06	2.32e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.38e-06	2.29e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.37e-06	2.28e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.35e-06	2.27e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—SRC—type 2 diabetes mellitus	2.35e-06	2.26e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.34e-06	2.25e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.32e-06	2.24e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.32e-06	2.23e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.31e-06	2.22e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.29e-06	2.2e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.28e-06	2.19e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.27e-06	2.19e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.27e-06	2.18e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	2.27e-06	2.18e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	2.25e-06	2.17e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.25e-06	2.16e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.23e-06	2.15e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.22e-06	2.14e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.2e-06	2.12e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.2e-06	2.11e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—SRC—type 2 diabetes mellitus	2.19e-06	2.11e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.19e-06	2.1e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	2.16e-06	2.08e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.14e-06	2.06e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.12e-06	2.04e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.1e-06	2.02e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.1e-06	2.02e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.1e-06	2.02e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.08e-06	2e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.06e-06	1.99e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.06e-06	1.98e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.06e-06	1.98e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.06e-06	1.98e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—IL6—type 2 diabetes mellitus	2.05e-06	1.97e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.04e-06	1.97e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.03e-06	1.96e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.02e-06	1.94e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.02e-06	1.94e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—IL6—type 2 diabetes mellitus	2e-06	1.93e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.98e-06	1.9e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.96e-06	1.89e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.96e-06	1.89e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.93e-06	1.86e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.93e-06	1.86e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.92e-06	1.85e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.92e-06	1.85e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.91e-06	1.84e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.91e-06	1.84e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.89e-06	1.82e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.89e-06	1.82e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—IL6—type 2 diabetes mellitus	1.88e-06	1.81e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.87e-06	1.8e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.87e-06	1.8e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.85e-06	1.78e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.78e-06	1.72e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—IL6—type 2 diabetes mellitus	1.75e-06	1.69e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.75e-06	1.69e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.74e-06	1.67e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.73e-06	1.67e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.72e-06	1.65e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.71e-06	1.65e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.68e-06	1.62e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—AKT1—type 2 diabetes mellitus	1.63e-06	1.57e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.62e-06	1.56e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.59e-06	1.53e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—IL6—type 2 diabetes mellitus	1.58e-06	1.52e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.56e-06	1.5e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	1.52e-06	1.46e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—IL6—type 2 diabetes mellitus	1.48e-06	1.42e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.46e-06	1.4e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	1.45e-06	1.4e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.4e-06	1.35e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.36e-06	1.31e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.34e-06	1.29e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	1.32e-06	1.27e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.32e-06	1.27e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.29e-06	1.24e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.22e-06	1.17e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.2e-06	1.16e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.19e-06	1.15e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.11e-06	1.07e-05	CbGpPWpGaD
